Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 11
Submit an article Journal homepage
2,338
Views
6
CrossRef citations to date
0
Altmetric
Diabetes

Safety and effectiveness of ipragliflozin in elderly versus non-elderly Japanese type 2 diabetes mellitus patients: 12 month interim results of the STELLA-LONG TERM study

Hiroshi MaegawaDepartment of Medicine, Shiga University of Medical Science, Shiga, Japan; Correspondence[email protected]
,
Kazuyuki TobeFirst Department of Internal Medicine, University of Toyama, Toyama, Japan;
,
Ichiro NakamuraMedical Science, Medical Affairs, Astellas Pharma Inc., Tokyo, Japan;
&
Satoshi UnoData Science, Development, Astellas Pharma Inc., Tokyo, Japan
Pages 1901-1910 | Received 19 Mar 2019, Accepted 21 Jul 2019, Published online: 29 Aug 2019

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ichiro Nakamura, Hiroshi Maegawa, Kazuyuki Tobe & Satoshi Uno. (2021) Real-World Evidence for Long-Term Safety and Effectiveness of Ipragliflozin in Japanese Patients with Type 2 Diabetes Mellitus: final Results of a 3-Year Post-Marketing Surveillance Study (STELLA-LONG TERM). Expert Opinion on Pharmacotherapy 22:3, pages 373-387.
Read now

Articles from other publishers (5)

Aika Miya, Akinobu Nakamura, Isao Yokota, Kyu Yong Cho, Hiraku Kameda, Hiroshi Nomoto, Takahiro Takase, Kazuno Omori, Mayuko Ono, So Nagai, Shinji Taneda, Hideaki Miyoshi & Tatsuya Atsumi. (2022) The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community‐based Integrated Care System 8‐items ( DASC ‐8): A cross‐sectional study of elderly patients with diabetes . Geriatrics & Gerontology International 22:8, pages 560-567.
Crossref
K. Tobe, H. Maegawa, I. NakamuraS. Uno. (2021) Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM). Diabetes mellitus 24:2, pages 141-155.
Crossref
Ichiro Nakamura, Hiroshi Maegawa, Kazuyuki Tobe & Satoshi Uno. (2021) Safety and Effectiveness of Ipragliflozin in Elderly Versus Non-elderly Japanese Patients with Type 2 Diabetes: Subgroup Analysis of STELLA-LONG TERM. Diabetes Therapy 12:5, pages 1359-1378.
Crossref
Kazuyuki Tobe, Hiroshi Maegawa, Ichiro Nakamura & Satoshi Uno. (2020) Safety and effectiveness of ipragliflozin in Japanese patients with type 2 diabetes mellitus and impaired renal function: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM). Diabetology International 12:2, pages 181-196.
Crossref
Ana M. Matos, Patrícia Calado, William Washburn & Amélia P. Rauter. 2021. Successful Drug Discovery. Successful Drug Discovery 111 157 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.